Click here to get full coverage on All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy - Yahoo Finance

All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy  Yahoo Finance

All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy - Yahoo Finance

Click here to get full coverage on Sentiment Review: Whats the beta of XFOR stock - Market Activity Report & AI Enhanced Trade Execution Alerts - baoquankhu1.vn

Sentiment Review: Whats the beta of XFOR stock - Market Activity Report & AI Enhanced Trade Execution Alerts  baoquankhu1.vn

Sentiment Review: Whats the beta of XFOR stock - Market Activity Report & AI Enhanced Trade Execution Alerts - baoquankhu1.vn

Click here to get full coverage on X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) Shares May Have Run Too Fast Too Soon - simplywall.st

X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) Shares May Have Run Too Fast Too Soon  simplywall.st

X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) Shares May Have Run Too Fast Too Soon - simplywall.st

Click here to get full coverage on XFOR - X4 Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

XFOR - X4 Pharmaceuticals Inc Latest Stock News & Market Updates  Stock Titan

XFOR - X4 Pharmaceuticals Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on X4 Pharmaceuticals: Betting On Mavorixafor For Chronic Neutropenia (NASDAQ:XFOR) - Seeking Alpha

X4 Pharmaceuticals: Betting On Mavorixafor For Chronic Neutropenia (NASDAQ:XFOR)  Seeking Alpha

X4 Pharmaceuticals: Betting On Mavorixafor For Chronic Neutropenia (NASDAQ:XFOR) - Seeking Alpha

Click here to get full coverage on Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross? - Nasdaq

Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross?  Nasdaq

Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross? - Nasdaq

Click here to get full coverage on $XFOR stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

$XFOR stock is up 15% today. Here's what we see in our data.  Quiver Quantitative

$XFOR stock is up 15% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on XFOR Stock Update: Stifel Raises Target Price to $10.00 | XFOR S - GuruFocus

XFOR Stock Update: Stifel Raises Target Price to $10.00 | XFOR S  GuruFocus

XFOR Stock Update: Stifel Raises Target Price to $10.00 | XFOR S - GuruFocus

Click here to get full coverage on XFOR’s Unexpected Surge: What’s Driving the Price? - timothysykes.com

XFOR’s Unexpected Surge: What’s Driving the Price?  timothysykes.com

XFOR’s Unexpected Surge: What’s Driving the Price? - timothysykes.com

Click here to get full coverage on Risk Analysis: Whats the beta of XFOR stock - Gap Down & Accurate Technical Buy Alerts - baoquankhu1.vn

Risk Analysis: Whats the beta of XFOR stock - Gap Down & Accurate Technical Buy Alerts  baoquankhu1.vn

Risk Analysis: Whats the beta of XFOR stock - Gap Down & Accurate Technical Buy Alerts - baoquankhu1.vn

Click here to get full coverage on X4 Pharmaceuticals (NASDAQ: XFOR) commences equity offering; 30-day 15% option - Stock Titan

X4 Pharmaceuticals (NASDAQ: XFOR) commences equity offering; 30-day 15% option  Stock Titan

X4 Pharmaceuticals (NASDAQ: XFOR) commences equity offering; 30-day 15% option - Stock Titan

Click here to get full coverage on X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance

X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on X4 Pharmaceuticals Stock (XFOR) Opinions on $60M Financing and Leadership Shake-Up | XFOR Stock News - Quiver Quantitative

X4 Pharmaceuticals Stock (XFOR) Opinions on $60M Financing and Leadership Shake-Up | XFOR Stock News  Quiver Quantitative

X4 Pharmaceuticals Stock (XFOR) Opinions on $60M Financing and Leadership Shake-Up | XFOR Stock News - Quiver Quantitative

Click here to get full coverage on Why X4 Pharmaceuticals, Inc. (XFOR) is Surging in 2025 - Yahoo Finance

Why X4 Pharmaceuticals, Inc. (XFOR) is Surging in 2025  Yahoo Finance

Why X4 Pharmaceuticals, Inc. (XFOR) is Surging in 2025 - Yahoo Finance

Click here to get full coverage on $XFOR stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

$XFOR stock is down 9% today. Here's what we see in our data.  Quiver Quantitative

$XFOR stock is down 9% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on XFOR Stock Skyrockets: Buy Now? - StocksToTrade

XFOR Stock Skyrockets: Buy Now?  StocksToTrade

XFOR Stock Skyrockets: Buy Now? - StocksToTrade

Click here to get full coverage on X4 Pharmaceuticals Inc (XFOR) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... - Yahoo Finance

X4 Pharmaceuticals Inc (XFOR) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ...  Yahoo Finance

X4 Pharmaceuticals Inc (XFOR) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... - Yahoo Finance

Click here to get full coverage on $XFOR stock is up 38% today. Here's what we see in our data. - Quiver Quantitative

$XFOR stock is up 38% today. Here's what we see in our data.  Quiver Quantitative

$XFOR stock is up 38% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on X4 Pharmaceuticals Expands Private Placement to $85M for Rare Disease Drug Development - Stock Titan

X4 Pharmaceuticals Expands Private Placement to $85M for Rare Disease Drug Development  Stock Titan

X4 Pharmaceuticals Expands Private Placement to $85M for Rare Disease Drug Development - Stock Titan

Click here to get full coverage on X4 Pharma rallies nearly 50% after $135 mln share offering - TradingView — Track All Markets

X4 Pharma rallies nearly 50% after $135 mln share offering  TradingView — Track All Markets

X4 Pharma rallies nearly 50% after $135 mln share offering - TradingView — Track All Markets

Click here to get full coverage on New Analyst Forecast: $XFOR Given $10 Price Target - Quiver Quantitative

New Analyst Forecast: $XFOR Given $10 Price Target  Quiver Quantitative

New Analyst Forecast: $XFOR Given $10 Price Target - Quiver Quantitative

Click here to get full coverage on Insider Purchase: Executive Chairman of $XFOR Buys 86,206 Shares - Quiver Quantitative

Insider Purchase: Executive Chairman of $XFOR Buys 86,206 Shares  Quiver Quantitative

Insider Purchase: Executive Chairman of $XFOR Buys 86,206 Shares - Quiver Quantitative

Click here to get full coverage on New Analyst Forecast: $XFOR Given $5.0 Price Target - Quiver Quantitative

New Analyst Forecast: $XFOR Given $5.0 Price Target  Quiver Quantitative

New Analyst Forecast: $XFOR Given $5.0 Price Target - Quiver Quantitative

Click here to get full coverage on XFOR: Full Enrollment of Phase 3 4WARD Trial Expected in 2H25… - Yahoo Finance

XFOR: Full Enrollment of Phase 3 4WARD Trial Expected in 2H25…  Yahoo Finance

XFOR: Full Enrollment of Phase 3 4WARD Trial Expected in 2H25… - Yahoo Finance

Click here to get full coverage on X4 Pharmaceuticals Announces Pricing of $135 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative

X4 Pharmaceuticals Announces Pricing of $135 Million Public Offering of Common Stock and Pre-Funded Warrants  Quiver Quantitative

X4 Pharmaceuticals Announces Pricing of $135 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative

Click here to get full coverage on XFOR Stock Offering Hits Range Between $2.85 and $2.95 - GuruFocus

XFOR Stock Offering Hits Range Between $2.85 and $2.95  GuruFocus

XFOR Stock Offering Hits Range Between $2.85 and $2.95 - GuruFocus

Click here to get full coverage on X4 Pharmaceuticals Completes $155.3 Million Public Offering of Common Stock | XFOR Stock News - Quiver Quantitative

X4 Pharmaceuticals Completes $155.3 Million Public Offering of Common Stock | XFOR Stock News  Quiver Quantitative

X4 Pharmaceuticals Completes $155.3 Million Public Offering of Common Stock | XFOR Stock News - Quiver Quantitative

Click here to get full coverage on Tuesday 10/28 Insider Buying Report: CRMD, XFOR - Nasdaq

Tuesday 10/28 Insider Buying Report: CRMD, XFOR  Nasdaq

Tuesday 10/28 Insider Buying Report: CRMD, XFOR - Nasdaq

Click here to get full coverage on X4 Pharmaceuticals Bolsters Financial Stability Amid Strategic Development - StocksToTrade

X4 Pharmaceuticals Bolsters Financial Stability Amid Strategic Development  StocksToTrade

X4 Pharmaceuticals Bolsters Financial Stability Amid Strategic Development - StocksToTrade

Click here to get full coverage on X4 Pharmaceuticals Eyes Future Growth with $135 Million Offering - StocksToTrade

X4 Pharmaceuticals Eyes Future Growth with $135 Million Offering  StocksToTrade

X4 Pharmaceuticals Eyes Future Growth with $135 Million Offering - StocksToTrade

Click here to get full coverage on Is X4 Pharmaceuticals Nearing a Breakthrough? - StocksToTrade

Is X4 Pharmaceuticals Nearing a Breakthrough?  StocksToTrade

Is X4 Pharmaceuticals Nearing a Breakthrough? - StocksToTrade

Click here to get full coverage on BEAST X for Bayesian phylogenetic, phylogeographic and phylodynamic inference - Nature

BEAST X for Bayesian phylogenetic, phylogeographic and phylodynamic inference  Nature

BEAST X for Bayesian phylogenetic, phylogeographic and phylodynamic inference - Nature

Click here to get full coverage on X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update  Yahoo Finance

X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

Click here to get full coverage on X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Target - Stocktwits

X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Target  Stocktwits

X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Target - Stocktwits

Click here to get full coverage on H.C. Wainwright Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Raises Target Price to $5 - 富途牛牛

H.C. Wainwright Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Raises Target Price to $5  富途牛牛

H.C. Wainwright Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Raises Target Price to $5 - 富途牛牛

Click here to get full coverage on Stifel Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Cuts Target Price to $7.5 - 富途牛牛

Stifel Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Cuts Target Price to $7.5  富途牛牛

Stifel Maintains X4 Pharmaceuticals(XFOR.US) With Buy Rating, Cuts Target Price to $7.5 - 富途牛牛

Click here to get full coverage on X4 Pharmaceuticals Inc. (XFOR) reports earnings - qz.com

X4 Pharmaceuticals Inc. (XFOR) reports earnings  qz.com

X4 Pharmaceuticals Inc. (XFOR) reports earnings - qz.com

Click here to get full coverage on X4 Pharmaceuticals announces board resignations and audit committee appointments - Investing.com

X4 Pharmaceuticals announces board resignations and audit committee appointments  Investing.com

X4 Pharmaceuticals announces board resignations and audit committee appointments - Investing.com

Click here to get full coverage on X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million - Yahoo Finance

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million  Yahoo Finance

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million - Yahoo Finance

Click here to get full coverage on Why XFOR stock attracts high net worth investors - Economic Impact on Stocks & Big Gains Small Investment - Улправда

Why XFOR stock attracts high net worth investors - Economic Impact on Stocks & Big Gains Small Investment  Улправда

Why XFOR stock attracts high net worth investors - Economic Impact on Stocks & Big Gains Small Investment - Улправда

Click here to get full coverage on X4 Pharmaceuticals stock rating raised to Buy by Stifel, price target up to $10 - Investing.com

X4 Pharmaceuticals stock rating raised to Buy by Stifel, price target up to $10  Investing.com

X4 Pharmaceuticals stock rating raised to Buy by Stifel, price target up to $10 - Investing.com

Click here to get full coverage on X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement - GlobeNewswire

X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement  GlobeNewswire

X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement - GlobeNewswire

Click here to get full coverage on X4 Pharmaceuticals Unveils Major 1-for-30 Stock Restructuring: Critical Nasdaq Compliance Plan Revealed - Stock Titan

X4 Pharmaceuticals Unveils Major 1-for-30 Stock Restructuring: Critical Nasdaq Compliance Plan Revealed  Stock Titan

X4 Pharmaceuticals Unveils Major 1-for-30 Stock Restructuring: Critical Nasdaq Compliance Plan Revealed - Stock Titan

Click here to get full coverage on Mag 7 Stocks Under $5 Stocks: ATNF RMBL LOOP XFOR – Breakout Setups – More Stocks Inside - FinancialContent

Mag 7 Stocks Under $5 Stocks: ATNF RMBL LOOP XFOR – Breakout Setups – More Stocks Inside  FinancialContent

Mag 7 Stocks Under $5 Stocks: ATNF RMBL LOOP XFOR – Breakout Setups – More Stocks Inside - FinancialContent

Click here to get full coverage on X4 Pharmaceuticals prices public offering at $2.90 per share - Investing.com

X4 Pharmaceuticals prices public offering at $2.90 per share  Investing.com

X4 Pharmaceuticals prices public offering at $2.90 per share - Investing.com

Click here to get full coverage on X4 Pharmaceuticals secures $60 million in financing, appoints new leadership - Investing.com

X4 Pharmaceuticals secures $60 million in financing, appoints new leadership  Investing.com

X4 Pharmaceuticals secures $60 million in financing, appoints new leadership - Investing.com

Click here to get full coverage on X4 Pharmaceuticals stock price target lowered to $3.50 at H.C. Wainwright - Investing.com

X4 Pharmaceuticals stock price target lowered to $3.50 at H.C. Wainwright  Investing.com

X4 Pharmaceuticals stock price target lowered to $3.50 at H.C. Wainwright - Investing.com

Click here to get full coverage on X4 Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

X4 Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations  Yahoo Finance

X4 Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Click here to get full coverage on Why XFOR stock is trending among retail traders - Weekly Risk Report & Risk Adjusted Swing Trade Ideas - Улправда

Why XFOR stock is trending among retail traders - Weekly Risk Report & Risk Adjusted Swing Trade Ideas  Улправда

Why XFOR stock is trending among retail traders - Weekly Risk Report & Risk Adjusted Swing Trade Ideas - Улправда

Click here to get full coverage on Why X4 Pharmaceuticals, Inc. (XFOR) is Surging in 2025 - Finviz

Why X4 Pharmaceuticals, Inc. (XFOR) is Surging in 2025  Finviz

Why X4 Pharmaceuticals, Inc. (XFOR) is Surging in 2025 - Finviz

Click here to get full coverage on X4 Pharma Secures $60 Mln PIPE Financing; CEO, CFO Resign; Replacements Named - Nasdaq

X4 Pharma Secures $60 Mln PIPE Financing; CEO, CFO Resign; Replacements Named  Nasdaq

X4 Pharma Secures $60 Mln PIPE Financing; CEO, CFO Resign; Replacements Named - Nasdaq

Click here to get full coverage on How XFOR stock valuations compare to rivals - July 2025 Opening Moves & Safe Entry Trade Reports - Улправда

How XFOR stock valuations compare to rivals - July 2025 Opening Moves & Safe Entry Trade Reports  Улправда

How XFOR stock valuations compare to rivals - July 2025 Opening Moves & Safe Entry Trade Reports - Улправда

Click here to get full coverage on How supply chain issues affect XFOR stock - July 2025 PreEarnings & Low Risk Investment Opportunities - Улправда

How supply chain issues affect XFOR stock - July 2025 PreEarnings & Low Risk Investment Opportunities  Улправда

How supply chain issues affect XFOR stock - July 2025 PreEarnings & Low Risk Investment Opportunities - Улправда

Click here to get full coverage on X4 Pharmaceuticals Announces Reverse Stock Split - Yahoo Finance

X4 Pharmaceuticals Announces Reverse Stock Split  Yahoo Finance

X4 Pharmaceuticals Announces Reverse Stock Split - Yahoo Finance

Click here to get full coverage on X4 Pharmaceuticals announces restructuring with 50% workforce cut - Investing.com

X4 Pharmaceuticals announces restructuring with 50% workforce cut  Investing.com

X4 Pharmaceuticals announces restructuring with 50% workforce cut - Investing.com

Click here to get full coverage on X4 Pharmaceuticals Closes $85M Private Placement Deal - TipRanks

X4 Pharmaceuticals Closes $85M Private Placement Deal  TipRanks

X4 Pharmaceuticals Closes $85M Private Placement Deal - TipRanks

Click here to get full coverage on Craig Adam R buys x4 pharmaceuticals shares for $249,997 - Investing.com

Craig Adam R buys x4 pharmaceuticals shares for $249,997  Investing.com

Craig Adam R buys x4 pharmaceuticals shares for $249,997 - Investing.com

Click here to get full coverage on X4 Pharmaceuticals To Implement 1-for-30 Reverse Stock Split On April 28 - Nasdaq

X4 Pharmaceuticals To Implement 1-for-30 Reverse Stock Split On April 28  Nasdaq

X4 Pharmaceuticals To Implement 1-for-30 Reverse Stock Split On April 28 - Nasdaq

Click here to get full coverage on Why XFOR stock is trending among retail traders - 2025 Technical Patterns & Expert Approved Trade Ideas - Улправда

Why XFOR stock is trending among retail traders - 2025 Technical Patterns & Expert Approved Trade Ideas  Улправда

Why XFOR stock is trending among retail traders - 2025 Technical Patterns & Expert Approved Trade Ideas - Улправда

Click here to get full coverage on X4 Pharmaceuticals stock price target raised to $5 from $3.50 at H.C. Wainwright - Investing.com

X4 Pharmaceuticals stock price target raised to $5 from $3.50 at H.C. Wainwright  Investing.com

X4 Pharmaceuticals stock price target raised to $5 from $3.50 at H.C. Wainwright - Investing.com

Click here to get full coverage on X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation - GlobeNewswire

X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation  GlobeNewswire

X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation - GlobeNewswire

Click here to get full coverage on ulpravda ru > 2026> Can XFOR stock sustain revenue growth - July 2025 Recap & Consistent Profit Trade Alerts - Улправда

ulpravda ru > 2026> Can XFOR stock sustain revenue growth - July 2025 Recap & Consistent Profit Trade Alerts  Улправда

ulpravda ru > 2026> Can XFOR stock sustain revenue growth - July 2025 Recap & Consistent Profit Trade Alerts - Улправда

Click here to get full coverage on X4 Pharmaceuticals Announces $60M Equity Financing - TipRanks

X4 Pharmaceuticals Announces $60M Equity Financing  TipRanks

X4 Pharmaceuticals Announces $60M Equity Financing - TipRanks

Click here to get full coverage on X4 Pharmaceuticals To Enact 1-for-30 Reverse Stock Split, Effective April 28, 2025 - Nasdaq

X4 Pharmaceuticals To Enact 1-for-30 Reverse Stock Split, Effective April 28, 2025  Nasdaq

X4 Pharmaceuticals To Enact 1-for-30 Reverse Stock Split, Effective April 28, 2025 - Nasdaq

Click here to get full coverage on X4 Pharmaceuticals Announces Board Resignations and Appointments - TipRanks

X4 Pharmaceuticals Announces Board Resignations and Appointments  TipRanks

X4 Pharmaceuticals Announces Board Resignations and Appointments - TipRanks

Click here to get full coverage on Aug Drivers: What is Osisko Development Corp. Equity Warrant s P E ratio telling us - July 2025 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Aug Drivers: What is Osisko Development Corp. Equity Warrant s P E ratio telling us - July 2025 Price Swings & AI Forecasted Entry/Exit Points  baoquankhu1.vn

Aug Drivers: What is Osisko Development Corp. Equity Warrant s P E ratio telling us - July 2025 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Click here to get full coverage on X4 Pharmaceuticals’ Unexpected Surge: Buy or Hold? - timothysykes.com

X4 Pharmaceuticals’ Unexpected Surge: Buy or Hold?  timothysykes.com

XFOR

Price Chart

Key Statistics

Technicals

About XFOR

Latest News

All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy - Yahoo Finance

Sentiment Review: Whats the beta of XFOR stock - Market Activity Report & AI Enhanced Trade Execution Alerts - baoquankhu1.vn

X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) Shares May Have Run Too Fast Too Soon - simplywall.st

Advanced Charts

Top Gainers

Top Losers